COVID-19(15) SARS-CoV-2(9) review(6) COVID‐19(6) the disease(5) SARS‐CoV‐2(4) coronavirus(4) therapy(3) clinical pharmacology(3) Evidence(3) US FDA(3) syndrome(3) Treatment(3) Antiviral(3) acute respiratory syndrome(3) review.(3) HIV(3) Tocilizumab(3) acute lung injury(3) Comprehensive(3) Prophylaxis.(3) Science(3) protease inhibitors(2) Methylprednisolone(2) respiratory distress(2) Antiretrovirals(2) nucleoside(2) Severe acute respiratory syndrome(2) Colchicine(2) effective therapy(2)